Yoshiyuki Yamamoto
Papers
1
Total Citations
14
H-Index
1
About
Dr. Yoshiyuki Yamamoto is a leading figure in Japanese urological oncology, whose research has fundamentally reshaped the understanding of prostate cancer management trends. His landmark nationwide multi-institutional study, "Changes in the trends of initial treatment for newly diagnosed prostate cancer in Japan" (2024, 14 citations), provides critical real-world evidence on how technological advancements have shifted clinical practice away from traditional androgen deprivation therapy. This work, building on his extensive contributions to the field, documents a pivotal transition in Japanese treatment paradigms, offering invaluable insights for optimizing patient outcomes. Dr. Yamamoto’s research is distinguished by its large-scale, population-based approach, which captures the dynamic interplay between emerging therapies and clinical decision-making. His findings are essential reading for clinicians and researchers seeking to understand the evolving landscape of prostate cancer care in Japan and its implications for global practice. Through his rigorous analysis, Dr. Yamamoto continues to influence treatment guidelines and inspire future investigations into personalized oncology.
Research Focus
Key Achievements
Top Papers
- 1